z-logo
Premium
Cancer research in the United States: A critical review of current status and proposal for alternative models
Author(s) -
Kantarjian Hagop M.,
Prat Ferran,
Steensma David P.,
Kurzrock Razelle,
Stewart David J.,
Sekeres Mikkael A.,
Leveque Joseph
Publication year - 2018
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31522
Subject(s) - medicine , cancer drugs , cancer , process (computing) , risk analysis (engineering) , management science , engineering ethics , computer science , engineering , operating system
This commentary reviews the evolution of the process of cancer research in the United States over the past 6 decades, from an academic‐based to drug industry‐based research, and the advantages and concerns. It proposes a new form of cancer research that involves the tumor‐specific cancer researchers as the primary drivers of the process, and outlines the benefits of such a model in relation to potential improved cost benefits, success rates, and research time lines.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here